ACTA PHARMACOL SIN 润色咨询

ACTA PHARMACOLOGICA SINICA

出版年份：2000 年文章数：1964 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：3.0% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1184906, encodeId=a160118490622, content=偏重的研究方向：肿瘤药理学<br>经验分享：发展前景不错，身边不少人靠这个杂志有了中科院1区的文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Sun Jan 16 18:19:31 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184796, encodeId=50531184e96d8, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：9月8号投稿，9月30号一审意见返回，给了大修两个月，两个审稿人一个意见温和，另一个提了14个问题大部分需要补实验，补完11月22日修回，12月7号二审后给了小修，审稿人对修稿满意，但又提了两个新问题，补了点小实验，1月4号修回。1月14号通知原则接收，但需要润色，编辑帮忙免费修改了摘要和标题，等待润色后最终接收。总的来说审稿意见对论文提升较大，杂志效率也高，国产期刊中口碑不错的杂志，前景看好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ef95586372, createdName=ms9000000496182733, createdTime=Sun Jan 16 12:04:26 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181949, encodeId=0e2f1181949c1, content=偏重的研究方向：药理学<br>经验分享：大侠们这个杂志Awaiting EIC Decision一般要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoJ80Ae3TNIibbjgNdXrhz5wIsCq4kqy2RgRqmMB0zM5iaTdPTOb6dwQicAJ7fOPVq6uSJwu97YN9UOg/132, createdBy=fe2a5325001, createdName=lxh, createdTime=Fri Jan 07 19:12:27 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086070, encodeId=221f10860e03b, content=什么是Protocol？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086069, encodeId=2ab110860698f, content=什么是comment？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084749, encodeId=c8c71084e4934, content=投稿命中率:5.0<br>偏重的研究方向：中药单体;心血管疾病;心血管药理<br>经验分享：12.24号周五投稿，12.27号，拒稿！数据量也很大，看其他的单体且数据量小的也都发表了，但是编辑直接给拒稿！理由是创新性没有达到期刊阈值！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5af65329453, createdName=星球大战, createdTime=Mon Dec 27 18:34:42 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962756, encodeId=af25962e56ab, content=审稿速度:12.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向：药理<br>经验分享：选好了期刊，碰对了审稿人，就很幸运，如果没有碰上nice的审稿人，可以给你拖一年, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=66d72098763, createdName=1851f60d27m, createdTime=Wed May 05 09:15:13 CST 2021, time=2021-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079071, encodeId=e84610e9071db, content=偏重的研究方向：心血管疾病<br>经验分享：一篇说当红炸子鸡卡格列净坏话的药物。投去JCI送审了。然后一个审稿专家说很好另一个极度犀利，指出很多不足。而后被拒。。然后就没有然后了，所有期刊没有送审直接拒，其中包括diabetes，diabetologia，cardiovascular diabetology，ebiomedicine。。。最后我基本知道，很可能得罪了资本。于是改投这里。审稿专家回来的意见是：The authors need to be congratulated on this fine piece of work. I could reel off a number of experiments that could enhance this work, but this would only lead to an small incremental increase in the quality of the work. The story is told in fine fashion using all the appropriate technologies and tool. Therefore I recommend the publication of this fine piece of work in its present state. 于是我更加确信！！！学术永远是被资本左右的。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epMQial4Iq3UndSEzcaEjhg1RQDst6kgHfAoIjI7bAHv0sKZzeLs87bBpYfmtGC27cpuEFMRSsRB6A/132, createdBy=c9642167189, createdName=公寓405寝室长, createdTime=Sat Dec 11 16:50:20 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523756, encodeId=a7b7523e569f, content=版面费是4000每页，彩图再加1000每页？还是我理解错了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=494, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7271735913, createdName=doris_Wang1214, createdTime=Thu Jun 16 02:10:00 CST 2016, time=2016-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063716, encodeId=c4d71063e1608, content=请问收药剂方向的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34665570110, createdName=ms6000000165714900, createdTime=Mon Oct 25 11:12:49 CST 2021, time=2021-10-25, status=1, ipAttribution=)]
    2022-01-16 1811e984f8m

    偏重的研究方向：肿瘤药理学
    经验分享：发展前景不错，身边不少人靠这个杂志有了中科院1区的文章。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1184906, encodeId=a160118490622, content=偏重的研究方向：肿瘤药理学<br>经验分享：发展前景不错，身边不少人靠这个杂志有了中科院1区的文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Sun Jan 16 18:19:31 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184796, encodeId=50531184e96d8, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：9月8号投稿，9月30号一审意见返回，给了大修两个月，两个审稿人一个意见温和，另一个提了14个问题大部分需要补实验，补完11月22日修回，12月7号二审后给了小修，审稿人对修稿满意，但又提了两个新问题，补了点小实验，1月4号修回。1月14号通知原则接收，但需要润色，编辑帮忙免费修改了摘要和标题，等待润色后最终接收。总的来说审稿意见对论文提升较大，杂志效率也高，国产期刊中口碑不错的杂志，前景看好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ef95586372, createdName=ms9000000496182733, createdTime=Sun Jan 16 12:04:26 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181949, encodeId=0e2f1181949c1, content=偏重的研究方向：药理学<br>经验分享：大侠们这个杂志Awaiting EIC Decision一般要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoJ80Ae3TNIibbjgNdXrhz5wIsCq4kqy2RgRqmMB0zM5iaTdPTOb6dwQicAJ7fOPVq6uSJwu97YN9UOg/132, createdBy=fe2a5325001, createdName=lxh, createdTime=Fri Jan 07 19:12:27 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086070, encodeId=221f10860e03b, content=什么是Protocol？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086069, encodeId=2ab110860698f, content=什么是comment？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084749, encodeId=c8c71084e4934, content=投稿命中率:5.0<br>偏重的研究方向：中药单体;心血管疾病;心血管药理<br>经验分享：12.24号周五投稿，12.27号，拒稿！数据量也很大，看其他的单体且数据量小的也都发表了，但是编辑直接给拒稿！理由是创新性没有达到期刊阈值！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5af65329453, createdName=星球大战, createdTime=Mon Dec 27 18:34:42 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962756, encodeId=af25962e56ab, content=审稿速度:12.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向：药理<br>经验分享：选好了期刊，碰对了审稿人，就很幸运，如果没有碰上nice的审稿人，可以给你拖一年, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=66d72098763, createdName=1851f60d27m, createdTime=Wed May 05 09:15:13 CST 2021, time=2021-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079071, encodeId=e84610e9071db, content=偏重的研究方向：心血管疾病<br>经验分享：一篇说当红炸子鸡卡格列净坏话的药物。投去JCI送审了。然后一个审稿专家说很好另一个极度犀利，指出很多不足。而后被拒。。然后就没有然后了，所有期刊没有送审直接拒，其中包括diabetes，diabetologia，cardiovascular diabetology，ebiomedicine。。。最后我基本知道，很可能得罪了资本。于是改投这里。审稿专家回来的意见是：The authors need to be congratulated on this fine piece of work. I could reel off a number of experiments that could enhance this work, but this would only lead to an small incremental increase in the quality of the work. The story is told in fine fashion using all the appropriate technologies and tool. Therefore I recommend the publication of this fine piece of work in its present state. 于是我更加确信！！！学术永远是被资本左右的。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epMQial4Iq3UndSEzcaEjhg1RQDst6kgHfAoIjI7bAHv0sKZzeLs87bBpYfmtGC27cpuEFMRSsRB6A/132, createdBy=c9642167189, createdName=公寓405寝室长, createdTime=Sat Dec 11 16:50:20 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523756, encodeId=a7b7523e569f, content=版面费是4000每页，彩图再加1000每页？还是我理解错了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=494, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7271735913, createdName=doris_Wang1214, createdTime=Thu Jun 16 02:10:00 CST 2016, time=2016-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063716, encodeId=c4d71063e1608, content=请问收药剂方向的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34665570110, createdName=ms6000000165714900, createdTime=Mon Oct 25 11:12:49 CST 2021, time=2021-10-25, status=1, ipAttribution=)]
    2022-01-16 ms9000000496182733

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享：9月8号投稿，9月30号一审意见返回，给了大修两个月，两个审稿人一个意见温和，另一个提了14个问题大部分需要补实验，补完11月22日修回，12月7号二审后给了小修，审稿人对修稿满意，但又提了两个新问题，补了点小实验，1月4号修回。1月14号通知原则接收，但需要润色，编辑帮忙免费修改了摘要和标题，等待润色后最终接收。总的来说审稿意见对论文提升较大，杂志效率也高，国产期刊中口碑不错的杂志，前景看好。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1184906, encodeId=a160118490622, content=偏重的研究方向：肿瘤药理学<br>经验分享：发展前景不错，身边不少人靠这个杂志有了中科院1区的文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Sun Jan 16 18:19:31 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184796, encodeId=50531184e96d8, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：9月8号投稿，9月30号一审意见返回，给了大修两个月，两个审稿人一个意见温和，另一个提了14个问题大部分需要补实验，补完11月22日修回，12月7号二审后给了小修，审稿人对修稿满意，但又提了两个新问题，补了点小实验，1月4号修回。1月14号通知原则接收，但需要润色，编辑帮忙免费修改了摘要和标题，等待润色后最终接收。总的来说审稿意见对论文提升较大，杂志效率也高，国产期刊中口碑不错的杂志，前景看好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ef95586372, createdName=ms9000000496182733, createdTime=Sun Jan 16 12:04:26 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181949, encodeId=0e2f1181949c1, content=偏重的研究方向：药理学<br>经验分享：大侠们这个杂志Awaiting EIC Decision一般要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoJ80Ae3TNIibbjgNdXrhz5wIsCq4kqy2RgRqmMB0zM5iaTdPTOb6dwQicAJ7fOPVq6uSJwu97YN9UOg/132, createdBy=fe2a5325001, createdName=lxh, createdTime=Fri Jan 07 19:12:27 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086070, encodeId=221f10860e03b, content=什么是Protocol？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086069, encodeId=2ab110860698f, content=什么是comment？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084749, encodeId=c8c71084e4934, content=投稿命中率:5.0<br>偏重的研究方向：中药单体;心血管疾病;心血管药理<br>经验分享：12.24号周五投稿，12.27号，拒稿！数据量也很大，看其他的单体且数据量小的也都发表了，但是编辑直接给拒稿！理由是创新性没有达到期刊阈值！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5af65329453, createdName=星球大战, createdTime=Mon Dec 27 18:34:42 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962756, encodeId=af25962e56ab, content=审稿速度:12.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向：药理<br>经验分享：选好了期刊，碰对了审稿人，就很幸运，如果没有碰上nice的审稿人，可以给你拖一年, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=66d72098763, createdName=1851f60d27m, createdTime=Wed May 05 09:15:13 CST 2021, time=2021-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079071, encodeId=e84610e9071db, content=偏重的研究方向：心血管疾病<br>经验分享：一篇说当红炸子鸡卡格列净坏话的药物。投去JCI送审了。然后一个审稿专家说很好另一个极度犀利，指出很多不足。而后被拒。。然后就没有然后了，所有期刊没有送审直接拒，其中包括diabetes，diabetologia，cardiovascular diabetology，ebiomedicine。。。最后我基本知道，很可能得罪了资本。于是改投这里。审稿专家回来的意见是：The authors need to be congratulated on this fine piece of work. I could reel off a number of experiments that could enhance this work, but this would only lead to an small incremental increase in the quality of the work. The story is told in fine fashion using all the appropriate technologies and tool. Therefore I recommend the publication of this fine piece of work in its present state. 于是我更加确信！！！学术永远是被资本左右的。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epMQial4Iq3UndSEzcaEjhg1RQDst6kgHfAoIjI7bAHv0sKZzeLs87bBpYfmtGC27cpuEFMRSsRB6A/132, createdBy=c9642167189, createdName=公寓405寝室长, createdTime=Sat Dec 11 16:50:20 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523756, encodeId=a7b7523e569f, content=版面费是4000每页，彩图再加1000每页？还是我理解错了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=494, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7271735913, createdName=doris_Wang1214, createdTime=Thu Jun 16 02:10:00 CST 2016, time=2016-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063716, encodeId=c4d71063e1608, content=请问收药剂方向的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34665570110, createdName=ms6000000165714900, createdTime=Mon Oct 25 11:12:49 CST 2021, time=2021-10-25, status=1, ipAttribution=)]
    2022-01-07 lxh

    偏重的研究方向：药理学
    经验分享：大侠们这个杂志Awaiting EIC Decision一般要多久呀？

    2

    展开2条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1184906, encodeId=a160118490622, content=偏重的研究方向：肿瘤药理学<br>经验分享：发展前景不错，身边不少人靠这个杂志有了中科院1区的文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Sun Jan 16 18:19:31 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184796, encodeId=50531184e96d8, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：9月8号投稿，9月30号一审意见返回，给了大修两个月，两个审稿人一个意见温和，另一个提了14个问题大部分需要补实验，补完11月22日修回，12月7号二审后给了小修，审稿人对修稿满意，但又提了两个新问题，补了点小实验，1月4号修回。1月14号通知原则接收，但需要润色，编辑帮忙免费修改了摘要和标题，等待润色后最终接收。总的来说审稿意见对论文提升较大，杂志效率也高，国产期刊中口碑不错的杂志，前景看好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ef95586372, createdName=ms9000000496182733, createdTime=Sun Jan 16 12:04:26 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181949, encodeId=0e2f1181949c1, content=偏重的研究方向：药理学<br>经验分享：大侠们这个杂志Awaiting EIC Decision一般要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoJ80Ae3TNIibbjgNdXrhz5wIsCq4kqy2RgRqmMB0zM5iaTdPTOb6dwQicAJ7fOPVq6uSJwu97YN9UOg/132, createdBy=fe2a5325001, createdName=lxh, createdTime=Fri Jan 07 19:12:27 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086070, encodeId=221f10860e03b, content=什么是Protocol？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086069, encodeId=2ab110860698f, content=什么是comment？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084749, encodeId=c8c71084e4934, content=投稿命中率:5.0<br>偏重的研究方向：中药单体;心血管疾病;心血管药理<br>经验分享：12.24号周五投稿，12.27号，拒稿！数据量也很大，看其他的单体且数据量小的也都发表了，但是编辑直接给拒稿！理由是创新性没有达到期刊阈值！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5af65329453, createdName=星球大战, createdTime=Mon Dec 27 18:34:42 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962756, encodeId=af25962e56ab, content=审稿速度:12.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向：药理<br>经验分享：选好了期刊，碰对了审稿人，就很幸运，如果没有碰上nice的审稿人，可以给你拖一年, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=66d72098763, createdName=1851f60d27m, createdTime=Wed May 05 09:15:13 CST 2021, time=2021-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079071, encodeId=e84610e9071db, content=偏重的研究方向：心血管疾病<br>经验分享：一篇说当红炸子鸡卡格列净坏话的药物。投去JCI送审了。然后一个审稿专家说很好另一个极度犀利，指出很多不足。而后被拒。。然后就没有然后了，所有期刊没有送审直接拒，其中包括diabetes，diabetologia，cardiovascular diabetology，ebiomedicine。。。最后我基本知道，很可能得罪了资本。于是改投这里。审稿专家回来的意见是：The authors need to be congratulated on this fine piece of work. I could reel off a number of experiments that could enhance this work, but this would only lead to an small incremental increase in the quality of the work. The story is told in fine fashion using all the appropriate technologies and tool. Therefore I recommend the publication of this fine piece of work in its present state. 于是我更加确信！！！学术永远是被资本左右的。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epMQial4Iq3UndSEzcaEjhg1RQDst6kgHfAoIjI7bAHv0sKZzeLs87bBpYfmtGC27cpuEFMRSsRB6A/132, createdBy=c9642167189, createdName=公寓405寝室长, createdTime=Sat Dec 11 16:50:20 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523756, encodeId=a7b7523e569f, content=版面费是4000每页，彩图再加1000每页？还是我理解错了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=494, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7271735913, createdName=doris_Wang1214, createdTime=Thu Jun 16 02:10:00 CST 2016, time=2016-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063716, encodeId=c4d71063e1608, content=请问收药剂方向的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34665570110, createdName=ms6000000165714900, createdTime=Mon Oct 25 11:12:49 CST 2021, time=2021-10-25, status=1, ipAttribution=)]
    2021-12-27 衣谷

    什么是Protocol？

    2

    展开2条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=1184906, encodeId=a160118490622, content=偏重的研究方向：肿瘤药理学<br>经验分享：发展前景不错，身边不少人靠这个杂志有了中科院1区的文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Sun Jan 16 18:19:31 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184796, encodeId=50531184e96d8, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：9月8号投稿，9月30号一审意见返回，给了大修两个月，两个审稿人一个意见温和，另一个提了14个问题大部分需要补实验，补完11月22日修回，12月7号二审后给了小修，审稿人对修稿满意，但又提了两个新问题，补了点小实验，1月4号修回。1月14号通知原则接收，但需要润色，编辑帮忙免费修改了摘要和标题，等待润色后最终接收。总的来说审稿意见对论文提升较大，杂志效率也高，国产期刊中口碑不错的杂志，前景看好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ef95586372, createdName=ms9000000496182733, createdTime=Sun Jan 16 12:04:26 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181949, encodeId=0e2f1181949c1, content=偏重的研究方向：药理学<br>经验分享：大侠们这个杂志Awaiting EIC Decision一般要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoJ80Ae3TNIibbjgNdXrhz5wIsCq4kqy2RgRqmMB0zM5iaTdPTOb6dwQicAJ7fOPVq6uSJwu97YN9UOg/132, createdBy=fe2a5325001, createdName=lxh, createdTime=Fri Jan 07 19:12:27 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086070, encodeId=221f10860e03b, content=什么是Protocol？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086069, encodeId=2ab110860698f, content=什么是comment？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084749, encodeId=c8c71084e4934, content=投稿命中率:5.0<br>偏重的研究方向：中药单体;心血管疾病;心血管药理<br>经验分享：12.24号周五投稿，12.27号，拒稿！数据量也很大，看其他的单体且数据量小的也都发表了，但是编辑直接给拒稿！理由是创新性没有达到期刊阈值！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5af65329453, createdName=星球大战, createdTime=Mon Dec 27 18:34:42 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962756, encodeId=af25962e56ab, content=审稿速度:12.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向：药理<br>经验分享：选好了期刊，碰对了审稿人，就很幸运，如果没有碰上nice的审稿人，可以给你拖一年, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=66d72098763, createdName=1851f60d27m, createdTime=Wed May 05 09:15:13 CST 2021, time=2021-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079071, encodeId=e84610e9071db, content=偏重的研究方向：心血管疾病<br>经验分享：一篇说当红炸子鸡卡格列净坏话的药物。投去JCI送审了。然后一个审稿专家说很好另一个极度犀利，指出很多不足。而后被拒。。然后就没有然后了，所有期刊没有送审直接拒，其中包括diabetes，diabetologia，cardiovascular diabetology，ebiomedicine。。。最后我基本知道，很可能得罪了资本。于是改投这里。审稿专家回来的意见是：The authors need to be congratulated on this fine piece of work. I could reel off a number of experiments that could enhance this work, but this would only lead to an small incremental increase in the quality of the work. The story is told in fine fashion using all the appropriate technologies and tool. Therefore I recommend the publication of this fine piece of work in its present state. 于是我更加确信！！！学术永远是被资本左右的。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epMQial4Iq3UndSEzcaEjhg1RQDst6kgHfAoIjI7bAHv0sKZzeLs87bBpYfmtGC27cpuEFMRSsRB6A/132, createdBy=c9642167189, createdName=公寓405寝室长, createdTime=Sat Dec 11 16:50:20 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523756, encodeId=a7b7523e569f, content=版面费是4000每页，彩图再加1000每页？还是我理解错了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=494, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7271735913, createdName=doris_Wang1214, createdTime=Thu Jun 16 02:10:00 CST 2016, time=2016-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063716, encodeId=c4d71063e1608, content=请问收药剂方向的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34665570110, createdName=ms6000000165714900, createdTime=Mon Oct 25 11:12:49 CST 2021, time=2021-10-25, status=1, ipAttribution=)]
    2021-12-27 衣谷

    什么是comment？

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=1184906, encodeId=a160118490622, content=偏重的研究方向：肿瘤药理学<br>经验分享：发展前景不错，身边不少人靠这个杂志有了中科院1区的文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Sun Jan 16 18:19:31 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184796, encodeId=50531184e96d8, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：9月8号投稿，9月30号一审意见返回，给了大修两个月，两个审稿人一个意见温和，另一个提了14个问题大部分需要补实验，补完11月22日修回，12月7号二审后给了小修，审稿人对修稿满意，但又提了两个新问题，补了点小实验，1月4号修回。1月14号通知原则接收，但需要润色，编辑帮忙免费修改了摘要和标题，等待润色后最终接收。总的来说审稿意见对论文提升较大，杂志效率也高，国产期刊中口碑不错的杂志，前景看好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ef95586372, createdName=ms9000000496182733, createdTime=Sun Jan 16 12:04:26 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181949, encodeId=0e2f1181949c1, content=偏重的研究方向：药理学<br>经验分享：大侠们这个杂志Awaiting EIC Decision一般要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoJ80Ae3TNIibbjgNdXrhz5wIsCq4kqy2RgRqmMB0zM5iaTdPTOb6dwQicAJ7fOPVq6uSJwu97YN9UOg/132, createdBy=fe2a5325001, createdName=lxh, createdTime=Fri Jan 07 19:12:27 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086070, encodeId=221f10860e03b, content=什么是Protocol？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086069, encodeId=2ab110860698f, content=什么是comment？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084749, encodeId=c8c71084e4934, content=投稿命中率:5.0<br>偏重的研究方向：中药单体;心血管疾病;心血管药理<br>经验分享：12.24号周五投稿，12.27号，拒稿！数据量也很大，看其他的单体且数据量小的也都发表了，但是编辑直接给拒稿！理由是创新性没有达到期刊阈值！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5af65329453, createdName=星球大战, createdTime=Mon Dec 27 18:34:42 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962756, encodeId=af25962e56ab, content=审稿速度:12.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向：药理<br>经验分享：选好了期刊，碰对了审稿人，就很幸运，如果没有碰上nice的审稿人，可以给你拖一年, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=66d72098763, createdName=1851f60d27m, createdTime=Wed May 05 09:15:13 CST 2021, time=2021-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079071, encodeId=e84610e9071db, content=偏重的研究方向：心血管疾病<br>经验分享：一篇说当红炸子鸡卡格列净坏话的药物。投去JCI送审了。然后一个审稿专家说很好另一个极度犀利，指出很多不足。而后被拒。。然后就没有然后了，所有期刊没有送审直接拒，其中包括diabetes，diabetologia，cardiovascular diabetology，ebiomedicine。。。最后我基本知道，很可能得罪了资本。于是改投这里。审稿专家回来的意见是：The authors need to be congratulated on this fine piece of work. I could reel off a number of experiments that could enhance this work, but this would only lead to an small incremental increase in the quality of the work. The story is told in fine fashion using all the appropriate technologies and tool. Therefore I recommend the publication of this fine piece of work in its present state. 于是我更加确信！！！学术永远是被资本左右的。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epMQial4Iq3UndSEzcaEjhg1RQDst6kgHfAoIjI7bAHv0sKZzeLs87bBpYfmtGC27cpuEFMRSsRB6A/132, createdBy=c9642167189, createdName=公寓405寝室长, createdTime=Sat Dec 11 16:50:20 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523756, encodeId=a7b7523e569f, content=版面费是4000每页，彩图再加1000每页？还是我理解错了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=494, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7271735913, createdName=doris_Wang1214, createdTime=Thu Jun 16 02:10:00 CST 2016, time=2016-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063716, encodeId=c4d71063e1608, content=请问收药剂方向的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34665570110, createdName=ms6000000165714900, createdTime=Mon Oct 25 11:12:49 CST 2021, time=2021-10-25, status=1, ipAttribution=)]
    2021-12-27 星球大战

    投稿命中率:5.0
    偏重的研究方向：中药单体;心血管疾病;心血管药理
    经验分享：12.24号周五投稿，12.27号，拒稿！数据量也很大，看其他的单体且数据量小的也都发表了，但是编辑直接给拒稿！理由是创新性没有达到期刊阈值！

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1184906, encodeId=a160118490622, content=偏重的研究方向：肿瘤药理学<br>经验分享：发展前景不错，身边不少人靠这个杂志有了中科院1区的文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Sun Jan 16 18:19:31 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184796, encodeId=50531184e96d8, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：9月8号投稿，9月30号一审意见返回，给了大修两个月，两个审稿人一个意见温和，另一个提了14个问题大部分需要补实验，补完11月22日修回，12月7号二审后给了小修，审稿人对修稿满意，但又提了两个新问题，补了点小实验，1月4号修回。1月14号通知原则接收，但需要润色，编辑帮忙免费修改了摘要和标题，等待润色后最终接收。总的来说审稿意见对论文提升较大，杂志效率也高，国产期刊中口碑不错的杂志，前景看好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ef95586372, createdName=ms9000000496182733, createdTime=Sun Jan 16 12:04:26 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181949, encodeId=0e2f1181949c1, content=偏重的研究方向：药理学<br>经验分享：大侠们这个杂志Awaiting EIC Decision一般要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoJ80Ae3TNIibbjgNdXrhz5wIsCq4kqy2RgRqmMB0zM5iaTdPTOb6dwQicAJ7fOPVq6uSJwu97YN9UOg/132, createdBy=fe2a5325001, createdName=lxh, createdTime=Fri Jan 07 19:12:27 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086070, encodeId=221f10860e03b, content=什么是Protocol？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086069, encodeId=2ab110860698f, content=什么是comment？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084749, encodeId=c8c71084e4934, content=投稿命中率:5.0<br>偏重的研究方向：中药单体;心血管疾病;心血管药理<br>经验分享：12.24号周五投稿，12.27号，拒稿！数据量也很大，看其他的单体且数据量小的也都发表了，但是编辑直接给拒稿！理由是创新性没有达到期刊阈值！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5af65329453, createdName=星球大战, createdTime=Mon Dec 27 18:34:42 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962756, encodeId=af25962e56ab, content=审稿速度:12.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向：药理<br>经验分享：选好了期刊，碰对了审稿人，就很幸运，如果没有碰上nice的审稿人，可以给你拖一年, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=66d72098763, createdName=1851f60d27m, createdTime=Wed May 05 09:15:13 CST 2021, time=2021-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079071, encodeId=e84610e9071db, content=偏重的研究方向：心血管疾病<br>经验分享：一篇说当红炸子鸡卡格列净坏话的药物。投去JCI送审了。然后一个审稿专家说很好另一个极度犀利，指出很多不足。而后被拒。。然后就没有然后了，所有期刊没有送审直接拒，其中包括diabetes，diabetologia，cardiovascular diabetology，ebiomedicine。。。最后我基本知道，很可能得罪了资本。于是改投这里。审稿专家回来的意见是：The authors need to be congratulated on this fine piece of work. I could reel off a number of experiments that could enhance this work, but this would only lead to an small incremental increase in the quality of the work. The story is told in fine fashion using all the appropriate technologies and tool. Therefore I recommend the publication of this fine piece of work in its present state. 于是我更加确信！！！学术永远是被资本左右的。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epMQial4Iq3UndSEzcaEjhg1RQDst6kgHfAoIjI7bAHv0sKZzeLs87bBpYfmtGC27cpuEFMRSsRB6A/132, createdBy=c9642167189, createdName=公寓405寝室长, createdTime=Sat Dec 11 16:50:20 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523756, encodeId=a7b7523e569f, content=版面费是4000每页，彩图再加1000每页？还是我理解错了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=494, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7271735913, createdName=doris_Wang1214, createdTime=Thu Jun 16 02:10:00 CST 2016, time=2016-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063716, encodeId=c4d71063e1608, content=请问收药剂方向的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34665570110, createdName=ms6000000165714900, createdTime=Mon Oct 25 11:12:49 CST 2021, time=2021-10-25, status=1, ipAttribution=)]
    2021-05-05 1851f60d27m

    审稿速度:12.0 | 投稿命中率:50.0 | 版面费用:2000.0
    偏重的研究方向：药理
    经验分享：选好了期刊，碰对了审稿人，就很幸运，如果没有碰上nice的审稿人，可以给你拖一年

    3

    展开3条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=1184906, encodeId=a160118490622, content=偏重的研究方向：肿瘤药理学<br>经验分享：发展前景不错，身边不少人靠这个杂志有了中科院1区的文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Sun Jan 16 18:19:31 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184796, encodeId=50531184e96d8, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：9月8号投稿，9月30号一审意见返回，给了大修两个月，两个审稿人一个意见温和，另一个提了14个问题大部分需要补实验，补完11月22日修回，12月7号二审后给了小修，审稿人对修稿满意，但又提了两个新问题，补了点小实验，1月4号修回。1月14号通知原则接收，但需要润色，编辑帮忙免费修改了摘要和标题，等待润色后最终接收。总的来说审稿意见对论文提升较大，杂志效率也高，国产期刊中口碑不错的杂志，前景看好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ef95586372, createdName=ms9000000496182733, createdTime=Sun Jan 16 12:04:26 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181949, encodeId=0e2f1181949c1, content=偏重的研究方向：药理学<br>经验分享：大侠们这个杂志Awaiting EIC Decision一般要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoJ80Ae3TNIibbjgNdXrhz5wIsCq4kqy2RgRqmMB0zM5iaTdPTOb6dwQicAJ7fOPVq6uSJwu97YN9UOg/132, createdBy=fe2a5325001, createdName=lxh, createdTime=Fri Jan 07 19:12:27 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086070, encodeId=221f10860e03b, content=什么是Protocol？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086069, encodeId=2ab110860698f, content=什么是comment？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084749, encodeId=c8c71084e4934, content=投稿命中率:5.0<br>偏重的研究方向：中药单体;心血管疾病;心血管药理<br>经验分享：12.24号周五投稿，12.27号，拒稿！数据量也很大，看其他的单体且数据量小的也都发表了，但是编辑直接给拒稿！理由是创新性没有达到期刊阈值！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5af65329453, createdName=星球大战, createdTime=Mon Dec 27 18:34:42 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962756, encodeId=af25962e56ab, content=审稿速度:12.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向：药理<br>经验分享：选好了期刊，碰对了审稿人，就很幸运，如果没有碰上nice的审稿人，可以给你拖一年, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=66d72098763, createdName=1851f60d27m, createdTime=Wed May 05 09:15:13 CST 2021, time=2021-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079071, encodeId=e84610e9071db, content=偏重的研究方向：心血管疾病<br>经验分享：一篇说当红炸子鸡卡格列净坏话的药物。投去JCI送审了。然后一个审稿专家说很好另一个极度犀利，指出很多不足。而后被拒。。然后就没有然后了，所有期刊没有送审直接拒，其中包括diabetes，diabetologia，cardiovascular diabetology，ebiomedicine。。。最后我基本知道，很可能得罪了资本。于是改投这里。审稿专家回来的意见是：The authors need to be congratulated on this fine piece of work. I could reel off a number of experiments that could enhance this work, but this would only lead to an small incremental increase in the quality of the work. The story is told in fine fashion using all the appropriate technologies and tool. Therefore I recommend the publication of this fine piece of work in its present state. 于是我更加确信！！！学术永远是被资本左右的。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epMQial4Iq3UndSEzcaEjhg1RQDst6kgHfAoIjI7bAHv0sKZzeLs87bBpYfmtGC27cpuEFMRSsRB6A/132, createdBy=c9642167189, createdName=公寓405寝室长, createdTime=Sat Dec 11 16:50:20 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523756, encodeId=a7b7523e569f, content=版面费是4000每页，彩图再加1000每页？还是我理解错了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=494, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7271735913, createdName=doris_Wang1214, createdTime=Thu Jun 16 02:10:00 CST 2016, time=2016-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063716, encodeId=c4d71063e1608, content=请问收药剂方向的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34665570110, createdName=ms6000000165714900, createdTime=Mon Oct 25 11:12:49 CST 2021, time=2021-10-25, status=1, ipAttribution=)]
    2021-12-11 公寓405寝室长

    偏重的研究方向：心血管疾病
    经验分享：一篇说当红炸子鸡卡格列净坏话的药物。投去JCI送审了。然后一个审稿专家说很好另一个极度犀利，指出很多不足。而后被拒。。然后就没有然后了，所有期刊没有送审直接拒，其中包括diabetes，diabetologia，cardiovascular diabetology，ebiomedicine。。。最后我基本知道，很可能得罪了资本。于是改投这里。审稿专家回来的意见是：The authors need to be congratulated on this fine piece of work. I could reel off a number of experiments that could enhance this work, but this would only lead to an small incremental increase in the quality of the work. The story is told in fine fashion using all the appropriate technologies and tool. Therefore I recommend the publication of this fine piece of work in its present state. 于是我更加确信！！！学术永远是被资本左右的。。。。

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1184906, encodeId=a160118490622, content=偏重的研究方向：肿瘤药理学<br>经验分享：发展前景不错，身边不少人靠这个杂志有了中科院1区的文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Sun Jan 16 18:19:31 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184796, encodeId=50531184e96d8, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：9月8号投稿，9月30号一审意见返回，给了大修两个月，两个审稿人一个意见温和，另一个提了14个问题大部分需要补实验，补完11月22日修回，12月7号二审后给了小修，审稿人对修稿满意，但又提了两个新问题，补了点小实验，1月4号修回。1月14号通知原则接收，但需要润色，编辑帮忙免费修改了摘要和标题，等待润色后最终接收。总的来说审稿意见对论文提升较大，杂志效率也高，国产期刊中口碑不错的杂志，前景看好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ef95586372, createdName=ms9000000496182733, createdTime=Sun Jan 16 12:04:26 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181949, encodeId=0e2f1181949c1, content=偏重的研究方向：药理学<br>经验分享：大侠们这个杂志Awaiting EIC Decision一般要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoJ80Ae3TNIibbjgNdXrhz5wIsCq4kqy2RgRqmMB0zM5iaTdPTOb6dwQicAJ7fOPVq6uSJwu97YN9UOg/132, createdBy=fe2a5325001, createdName=lxh, createdTime=Fri Jan 07 19:12:27 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086070, encodeId=221f10860e03b, content=什么是Protocol？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086069, encodeId=2ab110860698f, content=什么是comment？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084749, encodeId=c8c71084e4934, content=投稿命中率:5.0<br>偏重的研究方向：中药单体;心血管疾病;心血管药理<br>经验分享：12.24号周五投稿，12.27号，拒稿！数据量也很大，看其他的单体且数据量小的也都发表了，但是编辑直接给拒稿！理由是创新性没有达到期刊阈值！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5af65329453, createdName=星球大战, createdTime=Mon Dec 27 18:34:42 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962756, encodeId=af25962e56ab, content=审稿速度:12.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向：药理<br>经验分享：选好了期刊，碰对了审稿人，就很幸运，如果没有碰上nice的审稿人，可以给你拖一年, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=66d72098763, createdName=1851f60d27m, createdTime=Wed May 05 09:15:13 CST 2021, time=2021-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079071, encodeId=e84610e9071db, content=偏重的研究方向：心血管疾病<br>经验分享：一篇说当红炸子鸡卡格列净坏话的药物。投去JCI送审了。然后一个审稿专家说很好另一个极度犀利，指出很多不足。而后被拒。。然后就没有然后了，所有期刊没有送审直接拒，其中包括diabetes，diabetologia，cardiovascular diabetology，ebiomedicine。。。最后我基本知道，很可能得罪了资本。于是改投这里。审稿专家回来的意见是：The authors need to be congratulated on this fine piece of work. I could reel off a number of experiments that could enhance this work, but this would only lead to an small incremental increase in the quality of the work. The story is told in fine fashion using all the appropriate technologies and tool. Therefore I recommend the publication of this fine piece of work in its present state. 于是我更加确信！！！学术永远是被资本左右的。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epMQial4Iq3UndSEzcaEjhg1RQDst6kgHfAoIjI7bAHv0sKZzeLs87bBpYfmtGC27cpuEFMRSsRB6A/132, createdBy=c9642167189, createdName=公寓405寝室长, createdTime=Sat Dec 11 16:50:20 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523756, encodeId=a7b7523e569f, content=版面费是4000每页，彩图再加1000每页？还是我理解错了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=494, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7271735913, createdName=doris_Wang1214, createdTime=Thu Jun 16 02:10:00 CST 2016, time=2016-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063716, encodeId=c4d71063e1608, content=请问收药剂方向的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34665570110, createdName=ms6000000165714900, createdTime=Mon Oct 25 11:12:49 CST 2021, time=2021-10-25, status=1, ipAttribution=)]
    2016-06-16 doris_Wang1214

    版面费是4000每页，彩图再加1000每页？还是我理解错了？

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=1184906, encodeId=a160118490622, content=偏重的研究方向：肿瘤药理学<br>经验分享：发展前景不错，身边不少人靠这个杂志有了中科院1区的文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Sun Jan 16 18:19:31 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184796, encodeId=50531184e96d8, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：9月8号投稿，9月30号一审意见返回，给了大修两个月，两个审稿人一个意见温和，另一个提了14个问题大部分需要补实验，补完11月22日修回，12月7号二审后给了小修，审稿人对修稿满意，但又提了两个新问题，补了点小实验，1月4号修回。1月14号通知原则接收，但需要润色，编辑帮忙免费修改了摘要和标题，等待润色后最终接收。总的来说审稿意见对论文提升较大，杂志效率也高，国产期刊中口碑不错的杂志，前景看好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ef95586372, createdName=ms9000000496182733, createdTime=Sun Jan 16 12:04:26 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181949, encodeId=0e2f1181949c1, content=偏重的研究方向：药理学<br>经验分享：大侠们这个杂志Awaiting EIC Decision一般要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoJ80Ae3TNIibbjgNdXrhz5wIsCq4kqy2RgRqmMB0zM5iaTdPTOb6dwQicAJ7fOPVq6uSJwu97YN9UOg/132, createdBy=fe2a5325001, createdName=lxh, createdTime=Fri Jan 07 19:12:27 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086070, encodeId=221f10860e03b, content=什么是Protocol？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086069, encodeId=2ab110860698f, content=什么是comment？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084749, encodeId=c8c71084e4934, content=投稿命中率:5.0<br>偏重的研究方向：中药单体;心血管疾病;心血管药理<br>经验分享：12.24号周五投稿，12.27号，拒稿！数据量也很大，看其他的单体且数据量小的也都发表了，但是编辑直接给拒稿！理由是创新性没有达到期刊阈值！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5af65329453, createdName=星球大战, createdTime=Mon Dec 27 18:34:42 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962756, encodeId=af25962e56ab, content=审稿速度:12.0 | 投稿命中率:50.0 | 版面费用:2000.0<br>偏重的研究方向：药理<br>经验分享：选好了期刊，碰对了审稿人，就很幸运，如果没有碰上nice的审稿人，可以给你拖一年, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=66d72098763, createdName=1851f60d27m, createdTime=Wed May 05 09:15:13 CST 2021, time=2021-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079071, encodeId=e84610e9071db, content=偏重的研究方向：心血管疾病<br>经验分享：一篇说当红炸子鸡卡格列净坏话的药物。投去JCI送审了。然后一个审稿专家说很好另一个极度犀利，指出很多不足。而后被拒。。然后就没有然后了，所有期刊没有送审直接拒，其中包括diabetes，diabetologia，cardiovascular diabetology，ebiomedicine。。。最后我基本知道，很可能得罪了资本。于是改投这里。审稿专家回来的意见是：The authors need to be congratulated on this fine piece of work. I could reel off a number of experiments that could enhance this work, but this would only lead to an small incremental increase in the quality of the work. The story is told in fine fashion using all the appropriate technologies and tool. Therefore I recommend the publication of this fine piece of work in its present state. 于是我更加确信！！！学术永远是被资本左右的。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epMQial4Iq3UndSEzcaEjhg1RQDst6kgHfAoIjI7bAHv0sKZzeLs87bBpYfmtGC27cpuEFMRSsRB6A/132, createdBy=c9642167189, createdName=公寓405寝室长, createdTime=Sat Dec 11 16:50:20 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523756, encodeId=a7b7523e569f, content=版面费是4000每页，彩图再加1000每页？还是我理解错了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=494, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7271735913, createdName=doris_Wang1214, createdTime=Thu Jun 16 02:10:00 CST 2016, time=2016-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063716, encodeId=c4d71063e1608, content=请问收药剂方向的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34665570110, createdName=ms6000000165714900, createdTime=Mon Oct 25 11:12:49 CST 2021, time=2021-10-25, status=1, ipAttribution=)]
    2021-10-25 ms6000000165714900

    请问收药剂方向的文章吗？

    0

共172条页码: 3/18页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分